BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 8105942)

  • 21. Effect of amino acid based dialysate on peritoneal blood flow and permeability in stable CAPD patients: a potential role for nitric oxide?
    Douma CE; de Waart DR; Struijk DG; Krediet RT
    Clin Nephrol; 1996 May; 45(5):295-302. PubMed ID: 8738660
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nitrate in stable CAPD patients and during peritonitis.
    Douma CE; de Waart DR; Zemel D; Imholz AL; Koomen GC; Struijk DG; Krediet RT
    Adv Perit Dial; 1995; 11():36-40. PubMed ID: 8534733
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hypercalcemia in patients treated with CAPD.
    Orłowska-Kowalik G; Ksiazek A
    Ann Univ Mariae Curie Sklodowska Med; 2004; 59(2):479-84. PubMed ID: 16146134
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Outcome for continuous ambulatory peritoneal dialysis patients is not predicted by peritoneal permeability characteristics.
    Passadakis PS; Thodis ED; Panagoutsos SA; Selisiou CA; Pitta EM; Vargemezis VA
    Adv Perit Dial; 2000; 16():2-6. PubMed ID: 11045251
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Calcium and magnesium mass transfer in peritoneal dialysis patients using 1.25 mmol/L calcium, 0.25 mmol/L magnesium dialysis fluid.
    Hutchison AJ; Merchant M; Boulton HF; Hinchcliffe R; Gokal R
    Perit Dial Int; 1993; 13(3):219-23. PubMed ID: 8369353
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Transfer of native insulin through the peritoneal membrane during CAPD in non-diabetic and diabetic patients.
    Ersoy FF; Karayalcin U; Karayalcin B; Sapan M; Bozcuk H; Süleymanlar G; Yakupoglu G
    Adv Perit Dial; 1995; 11():119-22. PubMed ID: 8534683
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reversibility of parathyroid gland suppression in CAPD patients with low i-PTH levels.
    Montenegro J; Saracho R; González O; Moina I; Martínez I
    Clin Nephrol; 1997 Dec; 48(6):359-63. PubMed ID: 9438094
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Usefulness of the dialysis adequacy and transport test in peritoneal dialysis.
    Seo JJ; Kim YL; Park SH; Kim CD; Kim JC; Jang MH; Choi HJ
    Adv Perit Dial; 2005; 21():25-30. PubMed ID: 16686280
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vascular endothelial growth factor in peritoneal dialysis: a longitudinal follow-up.
    Zweers MM; Struijk DG; Smit W; Krediet RT
    J Lab Clin Med; 2001 Feb; 137(2):125-32. PubMed ID: 11174469
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-term follow-up of body size indices, residual renal function, and peritoneal transport characteristics in continuous ambulatory peritoneal dialysis.
    Twardowski ZJ; Moore HL; Prowant BF; Satalowich R
    Adv Perit Dial; 2009; 25():155-64. PubMed ID: 19886338
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Short peritoneal equilibration test: impact of preceding dwell time.
    Twardowski ZJ; Prowant BF; Moore HL; Lou LC; White E; Farris K
    Adv Perit Dial; 2003; 19():53-8. PubMed ID: 14763034
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Calcium balance and serum ionized calcium fluctuations in on-line haemodiafiltration in relation to ultrafiltration rate and dialysate calcium concentration.
    Malberti F; Corradi B; Tetta C; Imbasciati E
    Nephrol Dial Transplant; 1994; 9(12):1759-64. PubMed ID: 7708260
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of calcium antagonists on the peritoneal membrane in patients on CAPD.
    Vargemezis V; Pasadakis P; Thodis E
    Adv Perit Dial; 1989; 5():8-11. PubMed ID: 2577433
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-term effects of intermittent oral alphacalcidol, calcium carbonate and low-calcium dialysis (1.25 mmol L-1) on secondary hyperparathyroidism in patients on continuous ambulatory peritoneal dialysis.
    Brandi L; Nielsen PK; Bro S; Daugaard H; Olgaard K
    J Intern Med; 1998 Aug; 244(2):121-31. PubMed ID: 10095798
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Studies on the sodium concentration of dialysate solution for continuous ambulatory peritoneal dialysis].
    Nakayama M
    Nihon Jinzo Gakkai Shi; 1992 Aug; 34(8):913-20. PubMed ID: 1484410
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Acid base correction in bicarbonate CAPD patients.
    Feriani M; Biasioli S; Barbacini S; Ronco C; Chiaramonte S; Bragantini L; Dell'Aquila R; Milan M; Brendolan A; La Greca G
    Adv Perit Dial; 1989; 5():191-4. PubMed ID: 2577409
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of ionized sodium concentrations on ultrafiltration rate in peritoneal dialysis using lactate and lactate/bicarbonate solutions.
    La Milia V; Limardo M; Crepaldi M; Locatelli F
    Perit Dial Int; 2009; 29(2):158-62. PubMed ID: 19293352
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Peritoneal dialysis fluid (PDF) C++ and 1,25(OH)2D3 modulate peritoneal macrophage (PM0) antimicrobial activity in CAPD patients.
    Carozzi S; Nasini MG; Schelotto C; Caviglia PM; Barocci S; Cantaluppi A; Salit M
    Adv Perit Dial; 1990; 6():110-3. PubMed ID: 1982785
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The influence of dialysate calcium concentration on the PTH level in children undergoing CAPD.
    Sieniawska M; Roszkowska-Blaim M; Wojciechowska B
    Perit Dial Int; 1996; 16 Suppl 1():S567-9. PubMed ID: 8728272
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Measurement of serum ionized magnesium in CAPD patients.
    Saha HH; Harmoinen AP; Pasternack AI
    Perit Dial Int; 1997; 17(4):347-52. PubMed ID: 9284461
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.